US Stocks
/
Liminatus Pharma, Inc. Class A Share Price

Liminatus Pharma, Inc. Class A Share Price

NASDAQ: LIMN | Micro Cap
$3.77
-$0.04 (-1.05%) Last updated on 08 Oct, 2026 | 19:17 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Liminatus Pharma, Inc. Class A Stock Performance

Open
$3.84
Prev. Close
$3.81
Circuit Range
N/A
Day Range
$3.77 - $3.84
Year Range
$0.10 - $4.92
Volume
815
Average Traded
$3.78

Liminatus Pharma, Inc. Class A Share Price Today

As of 9 October 2026, Liminatus Pharma, Inc. Class A's share price is $3.77. The stock opened at $3.84, compared to its previous close of $3.81. During today's trading session, Liminatus Pharma, Inc. Class A's share price traded between $3.77 and $3.84, with an average price of $3.80. Over the past 52 weeks, the stock has recorded a high of $4.92 and a low of $0.10. In terms of performance, Liminatus Pharma, Inc. Class A's share price has risen by 1730.10% over the last six months and is up 171.22% on a year-on-year basis.

Liminatus Pharma, Inc. Class A Share Price Chart

$3.77$3.84
L
Show Current Price
H

Liminatus Pharma, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$89.55M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Liminatus Pharma, Inc. Class A

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.

Liminatus Pharma, Inc. Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.76
$3.77
-3.95%
Sep 2026
$3.69
$3.92
-11.20%
Aug 2026
$0.10
$4.42
+4,191.26%
Jul 2026
$0.10
$0.10
-9.65%
Jun 2026
$0.17
$0.11
-30.91%
May 2026
$0.21
$0.17
-19.90%
Apr 2026
$0.17
$0.21
+17.05%
Mar 2026
$0.24
$0.18
-30.71%
Feb 2026
$0.55
$0.25
-56.21%
Jan 2026
$0.64
$0.58
-9.52%
Dec 2025
$1.03
$0.64
-38.07%
Nov 2025
$1.39
$1.03
-25.54%

LIMN Share Price FAQs

What is Liminatus Pharma, Inc. Class A share price today?

chevron-up
Liminatus Pharma, Inc. Class A share price today is $3.77 as on October 8, 2026 at 7:17 pm IST.

What is the 52 week high and 52 week low of Liminatus Pharma, Inc. Class A stock?

chevron-up
The 52 week high of Liminatus Pharma, Inc. Class A stock is $4.92, while the 52 week low is $0.10 as of 8 Oct '26.

What is LIMN's market capitalisation today?

chevron-up
LIMN market capitalisation is $89.55M as of October 9, 2026, at 4:47 pm IST.

What is the 5 year returns of LIMN?

chevron-up
The 5 year returns of LIMN is -30.57% as on 8 Oct '26.

What is the high & low stock price of LIMN today?

chevron-up
LIMN stock price hit a high of $3.84 and low of $3.77 as of 8 Oct '26.

Can I buy LIMN shares in India?

chevron-up
Yes. You can buy LIMN in India by opening an international trading account.